Evidence map›Paper›PMID 40620359›Full record

ReviewFrontiers in chemistry2025

Progress in the application of hyperspectral imaging technology in quality detection and in the modernization of Chinese herbal medicines.

Yuting You, Lei Zhang, Zhuo Yu, Daqing Zhao, Xueyuan Bai, Wei Zhang

Abstract readReview
In one paragraph

Review in Frontiers in chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Optimal Detecting Part ofSensors (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuting You *Research Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
Lei Zhang *Research Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
Zhuo YuNortheast Asia Research Institute of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
Daqing ZhaoResearch Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
Xueyuan BaiResearch Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
Wei ZhangResearch Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperspectral imaging (HSI) technology integrates spectral analysis and image recognition with non-destructive and efficient advantages, and is widely used in the agriculture, geological exploration, military sectors, among others. Traditional Chinese medicine (TCM) has a long history of use in China, and to ensure the quality of TCM herbs, it is necessary to perform accurate quality assessments. It is also crucial to evaluate the active ingredients and changes in cultivation strategies and processing parameters over time. The use of HSI technology for the investigation of Chinese medicines has grown in importance, and recent advances in HSI have enabled the multi-dimensional non-destructive analyses of various components, origins, and growth statuses, thereby providing innovative solutions for modernization. This paper systematically reviews the application of HSI for detecting active ingredients, evaluating their quality, and recognizing the authenticity and species of Chinese herbal medicines. It clearly describes the limitations of hyperspectral technology in terms of data processing, emphasizes the importance of textural information, and suggests the application of HSI for large-scale detection.

Indexed as

Chinese herbal medicineclassification and identificationhyperspectral imagingnon-destructivequality evaluation

Identifiers

PMID40620359
PMCPMC12226550

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.